Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pacira Pharmaceuticals, Inc. (PCRX)    
$66.05 1.67 (2.47%) as of 4:30 Thu 4/17


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 33,320,000 as of 6/30
Market Cap: 2.20(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $25.84 - $80.43
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Major

Member Indexes:

      

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pacira Pharmaceuticals is a holding company. Through its subsidiaries, Co. is engaged in the development, commercialization and manufacture of pharmaceutical products, based on its DepoFoam drug delivery technology. Co.'s main product, EXPAREL, is marketed for the indication of postsurgical analgesia by infiltration, and is also in Phase 2 clinical trial for postsurgical analgesia-nerve block. Co.'s other products include: bupivacaine liposome injectable suspension for veterinary postsurgical analgesia; and DepoCyt(e), which is a sustained-release liposomal formulation of the chemotherapeutic agent cytarabine utilizing DepoFoam technology for the treatment of lymphomatous meningitis.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,853 1,853
Total Buy Value $0 $0 $62,003 $62,003
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 25,887 103,387 1,621,425 8,364,107
Total Sell Value $2,059,525 $6,148,440 $53,755,857 $227,899,199
Total People Sold 2 5 9 14
Total Sell Transactions 3 7 65 103
End Date 2014-01-19 2013-10-18 2013-04-19 2012-04-19

   
Records found: 207
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Longenecker John P Phd Director   –       •      –    2014-03-28 4 OE $29.90 $29,900 D/D 1,000 1,000     -
   Longenecker John P Phd Director   –       •      –    2014-03-28 4 AS $64.63 $64,630 D/D (1,000) 0 4%     
   Stack David M President, CEO and Chairman   •       •      –    2014-03-11 4 A $0.00 $0 D/D 221 1,208     -
   Patou Gary Chief Medical Officer   •       –      –    2014-03-11 4 A $0.00 $0 I/I 504 702     -
   Wicki Andreas Director   –       •      –    2014-03-06 4 S $80.11 $176,244 I/I (2,200) 1,667,307 14%     
   Wicki Andreas Director   –       •      –    2014-03-05 4 S $80.16 $1,818,651 I/I (22,687) 1,669,507 18%     
   Scibetta James S Chief Financial Officer   •       –      –    2013-12-30 4 AS $55.55 $555,500 D/D (10,000) 5,000 17%     
   Scibetta James S Chief Financial Officer   •       –      –    2013-12-30 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Stack David M President and CEO   •       •      –    2013-12-30 4 OE $1.61 $24,150 D/D 15,000 17,987     -
   Longenecker John P Phd Director   –       •      –    2013-12-30 4 OE $1.61 $4,025 D/D 2,500 2,500     -
   Longenecker John P Phd Director   –       •      –    2013-12-30 4 AS $55.55 $138,875 D/D (2,500) 0 17%     
   Stack David M President and CEO   •       •      –    2013-12-30 4 AS $55.84 $837,560 D/D (15,000) 2,987 17%     
   Stack David M President and CEO   •       •      –    2013-11-18 4 A $0.00 $0 D/D 414 2,987     -
   Patou Gary Chief Medical Officer   •       –      –    2013-11-18 4 A $0.00 $0 I/I 83 198     -
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-11-06 4 AS $50.60 $2,556,980 D/D (50,000) 0 27%     
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-11-06 4 OE $10.81 $540,500 D/D 50,000 50,000     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 OE $1.61 $32,200 D/D 20,000 20,000     -
   Patou Gary Chief Medical Officer   •       –      –    2013-10-01 4 AS $48.92 $978,400 D/D (20,000) 0 54%     
   Longenecker John P Phd Director   –       •      –    2013-09-30 4 OE $1.61 $4,025 D/D 2,500 2,500     -
   Scibetta James S Chief Financial Officer   •       –      –    2013-09-30 4 AS $46.74 $467,400 D/D (10,000) 5,000 65%     
   Scibetta James S Chief Financial Officer   •       –      –    2013-09-30 4 OE $1.61 $16,100 D/D 10,000 15,000     -
   Stack David M President and CEO   •       •      –    2013-09-30 4 AS $47.01 $705,741 D/D (15,000) 2,573 65%     
   Stack David M President and CEO   •       •      –    2013-09-30 4 OE $1.61 $24,150 D/D 15,000 17,573     -
   Longenecker John P Phd Director   –       •      –    2013-09-30 4 AS $46.74 $116,850 D/D (2,500) 0 65%     
   Markvicka Taunia Vice President, Commercial   •       –      –    2013-09-25 4 AS $47.00 $470,000 D/D (10,000) 0 55%     

  207 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed